Ipravent Inhalational Solution (Unit Dose)

Krajina: Austrália

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktívna zložka:

Ipratropium bromide

Dostupné z:

Pfizer Australia Pty Ltd

Trieda:

Medicine Registered

Príbalový leták

IPRAVENT
®

_INHALATION SOLUTION_
_Ipratropium bromide_
CONSUMER MEDICINE INFORMATION

WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about Ipravent.
It does not contain all the available
information. It does not take the
place of talking to your doctor or
pharmacist.
All medicines have risks and
benefits. Your doctor has weighed
the risks of you using this medicine
against the benefits they expect it
will have for you.
IF YOU HAVE ANY CONCERNS ABOUT
USING THIS MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT IPRAVENT
INHALATION
SOLUTION IS USED FOR
Ipravent belongs to a group of
medicines known as anticholinergic
bronchodilators. Anticholinergic
bronchodilators work by relaxing the
bronchial tubes (air passages) that
carry air in and out of your lungs.
This makes breathing less difficult.
Ipravent is used to relieve the
symptoms of lung disease such as
asthma or chronic obstructive
bronchitis. It may be used in other
conditions where breathing is
difficult, such as after surgery or
during assisted ventilation.
Ipravent may be used for the
management of other conditions that
are not mentioned above. Your
doctor will be able to tell you about
the specific condition for which you
have been prescribed Ipravent.
ASK YOUR DOCTOR IF YOU HAVE ANY
QUESTIONS ABOUT WHY IT HAS BEEN
PRESCRIBED FOR YOU.
This medicine is available only with
a doctor's prescription.
BEFORE YOU USE IT
_WHEN YOU MUST NOT USE IT_
DO NOT USE IPRAVENT IF YOU HAVE AN
ALLERGY TO IPRATROPIUM BROMIDE OR
ANY OF THE INGREDIENTS LISTED AT THE
END OF THIS LEAFLET.
IF YOU ARE NOT SURE IF THIS APPLIES TO
YOU, CHECK WITH YOUR DOCTOR.
IPRAVENT SHOULD NOT BE GIVEN TO A
NEWBORN BABY.
DO NOT USE IT AFTER THE EXPIRY DATE
(EXP) PRINTED ON THE PACK.
If you use it after the expiry date has
passed, it may not work as well.
DO NOT USE IT IF THE PACKAGING IS
TORN OR SHOWS SIGNS OF TAMPERING.
_BEFORE YOU START TO USE IT_
TELL YOUR DOCTOR IF
1. YOU HAVE ANY ALLERGIES TO:
�

Súhrn charakteristických

 
Version: pfpipraj10512 
Supersedes: pupiprau10807 

Page 1 of 8 
PRODUCT INFORMATION 
IPRAVENT
®
 INHALATION SOLUTION – UNIT DOSE 
NAME OF THE MEDICINE 
Ipratropium Bromide BP 
Ipratropium  bromide  is  a  quaternary  isopropyl  derivative  of  atropine.    Its  chemical  name  is 
(1R,  3r,  5S,  8r)-3-[(RS)  -  (3  -  hydroxy  -  2  -  phenylpropanoyl)  oxy]  -  8  -  methyl  -  8  -  (1  - 
methylethyl)  -  8  -  azoniabicyclo  [3.2.1]  octane  bromide.    It  appears  as  a  white  or  almost 
white, crystalline powder, soluble in water, freely soluble in methanol and slightly soluble in 
alcohol.  The addition of an N-isopropyl group distinguishes the molecule from atropine and 
is responsible for a lower lipid solubility. 
The structural formula is represented below. 

Molecular Formula:  C
20
H
30
BrNO
3

Molecular Weight: 
412.4 
CAS Number:   
22254-24-6 
DESCRIPTION 
Ipravent  Inhalation  Solution  in  Sterinebs  is  a  clear,  colourless  to  almost  colourless,  sterile 
solution.    It  contains  ipratropium  bromide  monohydrate  261 g/mL  equivalent  to  250 g 
ipratropium bromide (anhydrous) or ipratropium bromide monohydrate 522 g/mL equivalent 
to 500 g ipratropium bromide (anhydrous) and Sodium Chloride BP in Water for Injections 
BP.  It does not contain preservatives. 

Version: pfpipraj10512 
Supersedes: pupiprau10807 

Page 2 of 8 
PHARMACOLOGY 
CLASS OF DRUG 
Anticholinergic bronchodilator. 
MODE OF ACTION 
Ipratropium bromide allows bronchodilation by inhibiting cholinergic bronchomotor tone and 
consequently,  vagal  reflexes  mediating  bronchoconstriction  are  blocked.    In  this  respect 
ipratropium bromide is fundamentally different from   agonists.
 The onset of bro